期刊文献+

从D-二聚体检测体系的变更谈检验与临床沟通 被引量:4

Discussion on the communication between clinicians and laboratory for the change of D-dimer detection system
下载PDF
导出
摘要 本文从检测体系变更实例出发阐述实验室如何与临床做到有效的沟通。在D-二聚体检测体系的变更过程中,通过四个阶段的分步工作做到了平稳过渡。第一阶段:在更换新试剂之前,平行检测2种试剂体系间结果的相关性,从检验方法学角度分析数据;第二阶段:以临床沟通会的形式召集相关临床科室的医生,汇报前期实验数据,并在此基础上听取临床医生的意见和建议;第三阶段:根据临床需求和建议,进一步进行相应实验,并及时反馈给临床医生;第四阶段:在得到临床医生的认可后开始更换试剂,并在更换试剂后及时交流和反馈。通过以上工作,检验科顺利完成了D-二聚体检测体系的变更,消除了可能存在的医疗隐患。 This paper introduces how to achieve an efficient communication between clinical laboratory and clinicians .During this procedure of D-dimer detection system transition , four-stage work has been addressed to ensure a sufficient and smooth communication .In the first stage, the comparison evaluation between 2 reagent systems is performed, and the results were analyzed in the view of methodology .In the second stage, a clinical communication meeting is held , and the related cliaicians are invited .The evaluation results are reported to the clinicians , and the clinicians′feedback and suggestions are collected .In the third stage , more tests are performed according to clinicians′demands and suggestions .All the actions and results are feedback to clinicians .In the final stage , confirmed by the clinicians, we change the reagent system and set a dedicate person to answer the questions and keep communication with clinicians.By means of these four-stage works, the old D-dimer reagent system is changed smoothly in our laboratory . The potential risk of medical misdiagnosis is eliminated .
作者 崔巍 郭野
出处 《检验医学》 CAS 2015年第4期311-313,共3页 Laboratory Medicine
关键词 检验医学 临床沟通 D-二聚体 Laboratory medicine Clinical communication D-dimer
  • 相关文献

参考文献7

  • 1SARTORI M, COSMI B, rule and D-dimer for the deep vein thrombosis [ J] 10( 11 ) :2264-2269. LEGNANI C, et al. Wells diagnosis of isolated distal J Thromb Haemost, 2012,.
  • 2BATES SM. D-dimer assays in diagnosis and management of thrombotic and bleeding disorders [ J]. Semin Thromb Hemost, 2012, 38 (7) :673-682.
  • 3KHALAFALLAH A, JARVIS C, MORSE M, et al. Evaluation of the innovanee D-dimer assay for the diagnosis of disseminated intravascular coagulopathy in different clinical settings [ J ]. Clin Appl Thromb Hemost, 2014,20( 1 ) :91-97.
  • 4LUXEMBOURG B, SCHWONBERG J, HECKING C, et al. Performance of five D-dimer assays for the exclusion of symptomatic distal leg vein thrombosis [ J]. Thromb Haemost, 2012, 107(2) :369-378.
  • 5郭野,寿玮龄,吴卫,陈倩,郝晓培,崔巍.INNOVANCE试验和PLUS试验检测D-二聚体方法比较[J].中华检验医学杂志,2013,36(7):638-642. 被引量:9
  • 6MOUNTAIN D, JACOBS I, HAIG A. The VIDAS D- dimer test for venous thromboembolism: a prospective surveillance study shows maintenance of sensitivity and specificity when used in normal clinical practice [ J ]. J Emerg Med, 2007, 25(4) :464-471.
  • 7National Committee for Clinical Laboratory Standards. Interference testing in clinical chemistry. Approved guideline-secong editionguideline [ S ]. EPO7-A, NCCLS, 2005.

二级参考文献16

  • 1Tripodi A. D-Dimer testing in laboratory practice. Clin Chern, 2011,57: 1256-1262.
  • 2WangY, LiuZH. ZhangHL, etal. Predictive value ofD-Dimer test for recurrent venous thromboembolism at hospital discharge in patients with acute pulmonary embolism.J Thromb Thrombolysis, 2011 , 32 :410-416.
  • 3Elias-Hernandez T, Otero-Candelera R, Ferncndez-Jirnenez D. et al. Clinical usefulness of three quantitative D-Dimer tests in outpatients with suspected deep vein thrombosis. Rev Clin Esp, 2012,212:235-241.
  • 4Coen Herak D, Milos M, Zadro R. Evaluation of the Innovance D- Dimer analytical performance. Clin Chern Lab Med, 2009, 47 : 945-951.
  • 5Freyburger G, Labrouche S. Comparability of D-Dimer assays in clinical samples. Semin Vase Med, 2005, 5 :328-339.
  • 6National Committee for Clinical Laboratory Standards. Interference testing in clinical chemistry. Approved guideline-secong editionguideline. EP7 -A2[CJ. Pennsylvania: NCCLS, 2005.
  • 7Mountain D,Jacobs I, Haig A. The VIDAS D-Dimer test for venous thromboembolism: a prospective surveillance study shows maintenance of sensitivity and specificity when used in normal clinical practice. AmJ Emerg Med, 2007, 25 :464-471.
  • 8Righini M, Perrier A, De Moerloose P, et al. D-Dimer for venous thromboembolism diagnosis: 20 years later.J Thromb Haemost, 2008, 6: 1059-1071.
  • 9Salvagno GL, Lippi G, Manzato F, et al. Analytical comparison ofAxSYM , HemosIL DD HS and Innovance D-Dimer immunoassays with the Vidas D-Dimer. IntJ Lab Hematol, 2009, 31 :475-477.
  • 10MichielsJ J, Gadisseur A, van der Planken M, et al. Different accuracies of rapid enzyme-linked immunosorbent, turbidimetric, and agglutination D- Dimer assays for thrombosis exclusion: impact on diagnostic work-ups of outpatients with suspected deep vein thrombosis and pulmonary embolism. Semin Thromb Hemost, 2006, 32 :678-693.

共引文献8

同被引文献51

  • 1中国合格评定国家认可委员会.CNAS-CL02:医学实验室质量和能力认可准则[EB/OL ]. (2013-11-22 ) [2014-11-01 ].http ://www. cnas. org. cn/images/rkgf/sysrk/jbzz/2013/12/20/lC3A61EEC69A825B0FD01ECD986D9B78.pdf.
  • 2Simko R J, Tsung FF, Stanek EJ. Activated clotting time versus activated partial thromboplastin time for therapeutic monitoring of heparin [ J ]. Ann Pharmacother, 1995, 29 ( 10 ) : 1015-1021.
  • 3Fritsma GA, Dembitzer FR, Randhawa A, et al. Recommendations for appropriate activated partial thromboplastin time reagent selection and utilization [ J ], Am J Clin Pathol, 2012, 137(6) :904-908. DOI:IO. 1309/AJCP3J1ZKYBFQXJM.
  • 4Olson JD, Cunningham MT, Higgins RA, et al. D-dimer: simple - test, tough problems[ J]. Arch Pathol Lab Med, 2013, 137 (8) : 1030-1038. DOI : 10. 5858/arpa. 2012-0296-CP.
  • 5Will A. Neonatal haemostasis and the management of neonatal thrombosis[ J]. Br J Haematol, 2015, 169 ( 3 ) : 324-332. DOI: 10. llll/bjh. 13301.
  • 6Favaloro E J, Franchini M, Lippi G. Aging hemostasis: changes to laboratory markers of hemostasis as we age - a narrative review [ J]. Semin Thromb Hemost, 2014, 40 (6) : 6214533. DOI: 10. 1055/s-0034-1384631.
  • 7Franchini M, Crestani S, Frattini F, et al. ABO blood group and yon Willebrand factor: biological implications[ J]. Clin Chem Lab Med, 2014, 52(9):1273-1276. DOI:10. 1515/cclm-2014-0564.
  • 8Chen Q, Shou W, Wu W, et al. Biological and analytical variations of 16 parameters related to coagulation screening tests and the activity of coagulation factors [ J ]. Semin Thromb Hemost, 2015,41 (3) :336-341. DOI : 10. 1055/s-0034-1543994.
  • 9Shou W, Chen Q, Wu W, et al. Biological Variations of Lupus Anticoagulant, Antithrombin, Protein C, Protein S, and yon Willebrand Factor Assays [ J 1. Semin Thromb Hemost, 2016, 42 ( 1 ) :87-92. DOI:10. 1055/s-0035-1552588.
  • 10Lippi G, Salvagno GL, Montagnana M, et al. Quality standards for sample collection in coagulation testing [ J ]. Semin Thromb Hemost, 2012, 38 ( 6 ) : 565-575. DOI: 10. 1055/s-0032- 1315961.

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部